- The European Patent Office notifies Galena Biopharma (GALE +7.6%) that it intends to grant a patent that covers the use of the company's NeuVax drug as a vaccine for the prevention of relapse in breast-cancer patients.
- The patent is due to expire in April 2028. (PR)
Galena to receive EU patent for breast-cancer vaccine
Recommended For You
More Trending News
About SLS Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
SLS | - | - |
SELLAS Life Sciences Group, Inc. |